By PolyCrystalLine S.R.L.
To get in touch with PolyCrystalLine S.R.L., simply fill out the form below.
Subscribe to Supplier
PCL bringing latest crystalline form insights and technologies to CPhI Madrid
Bologna, Italy: – Crystalline form specialist CRO PolyCrystalLine Srl. (PCL) will return to CPhI Worldwide when it opens in Madrid in October.
The Italian-based specialist laboratory and research partner will be meeting clients and presenting PolyCrystalLine’s latest services and innovations from its stand L9 in Hall 12 at IFEMA, Feria de Madrid.
The company’s CEO, Dr. Stefano Luca Giaffreda will again lead the PolyCrystalLine team at CPhI.
Crystal form optimization
The company will be showcasing new technology transfer and collaborative research opportunities, harnessing the shared experties of PolyCrystalLine and its research partner CSV Active in synthesis optimization, sourcing of key intermediates, crystal form optimization, polymorph and co-crystal screening, analysis and production.
Dr. Giaffreda plans to use the event to build further partner contacts in API development, solid state research, analytical support, method development and validation.
“We’re hoping our clients and potential partners will take a little time to meet us and share our visions on the constantly changing pharmaceutical market,” said Dr. Giaffredda.
CPhI delegates wishing to meet Dr. Giafredda and the team are invited to email Luca Covello firstname.lastname@example.org to arrange appointments.
PolyCrystalLine Srl has rapidly established prominence in research and characterization of crystal forms and solid-state compounds, particularly in the pharmaceutical field.
The company has its roots in academia, building on research and collaborative networks to form a business. Academic knowledge is combined with business skills, employing a close relationship with scientific methodology to construct original, forward-thinking approaches to solve technical, patenting and commercial problems.
PolyCrystalLine’s extensive experience in the characterization of solid-state compounds and the study of polymorphism has been leveraged into development of explicit and adaptable research protocols that can be adjusted to meet the requirements of the pharmaceutical industry. It investigates the thermal behaviour of pharmaceutical compounds through a wide range of methods including X-ray powder diffraction, calorimetric, thermogravimetric and evolved gas analysis.
The company is able to meet a diverse range of research needs and budget requirements, from comprehensive analysis of APIs and compounds/solvates to rapid low cost screening and studies that involve patent issues.
It can provide crystallization processes utilising modular approaches ranging from milligrams to half kilogram scale, along with expert knowledge in regards to the optimization of different parameters during the crystallization processes to achieve desired crystal forms, yields, particle size, etc.
PolyCrystalLine clients include AET, Bracco, Chemi, DeveloPharma, Dipharma, Novartis, Polpharma, Rivopharm and Zach System.
About CPhI 2015
CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing providing delegates and exhibitors opportunities to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators, as well as gain insights on latest industry trends.
Now in its 26th year, the 2015 event is a three-day event opening October 13 at IFEMA, Feria de Madrid, Spain. Last year’s even in Paris attracted almost 36,500 delegates and 2,500 exhibitor companies from more than 150 countries worldwide.
The CPhl Worldwide show is being held alongside three other zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events.
The Pre-Connect Conference on October 12 brings together senior representatives and key stakeholders from all segments of the industry for a series of market-led educational modules on the latest trends and topics with networking and partnering opportunities.
The CPhI Pharma Awards, presented on the first evening of the conference, honor innovative companies and leaders. The previous three categories (formulation, process development and packaging) have now been expanded to eight awards, now additionally honoring best innovations in biologic drug development and manufacturing, supply chain & logistic management, manufacturing technology, APIs and excipients, as well as CEO of the Year.
The CPhI series is staged by leading Global B2B Events Organizer and Publisher UBM Live More information at: http://www.cphi.com/europe/home